Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/3048
Title: Fe3O4@SiO2@(CH2)3@4-(2-Aminoethyl)morpholine as a Reusable Magnetic Organocatalyst for Synthesis of Pyrano[3,2‑c]chromene Derivatives Along with Docking Study
Authors: Leila Amiri-Zirtol
Keywords: Pyrano[3,2-c]chromene
Magnetically catalyst
Docking
Topoisomerase
Issue Date: 15-Apr-2026
Abstract: Pyrano[3,2-c]chromene derivatives, as an important category of heterocyclic compounds, have received much attention due to their various biological activities. Different synthetic methods using various catalysts have been reported for the synthesis of these compounds. Here, a green, magnetically separable catalyst functionalized with nitrogen-containing groups was used for the synthesis of a series of pyrano[3,2-c]chromene derivatives. The target compounds were synthesized by employing the catalytic activity of the previously synthesized composite under environmentally friendly and mild conditions. The reaction proceeded efficiently in a water/ethanol mixture within a short time and resulted in high product yields. A multicomponent reaction was used to synthesize pyrano[3,2-c]chromene derivatives from malononitrile, 4-hydroxycoumarin and various aldehydes. The purity of the final compounds was checked by melting point determination and comparison with literature values. Since pyrano[3,2-c]chromene derivatives are proposed as potential inhibitors of DNA topoisomerases, especially TOPII, in the second part of this study, a computational study was performed targeting the DNA-TOPII complex. The results revealed that some of the synthesized compounds are known to inhibit topoisomerases, supporting their role as promising anticancer agents.
Description: Vol38, No.1,p234
URI: http://111.93.178.142:25000/jspui/handle/123456789/3048
Appears in Collections:Vol38, No. 1, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol38, No.1,p234187.29 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.